We're excited to share our op-ed, "Building the future of health care: the need for investment in radiopharmaceutical commercialization", which was published yesterday by @iPoliticsCA . You can read the full article on the iPolitics website:

RT @IsotopesCanada: The Canadian Radiotheranostics Leaders’ Summit 2025 starts tomorrow! We can’t wait to welcome Canadian and internationa….

The Canadian Radiotheranostics Leaders' Summit 2025 is just two days away! We're glad to partner with the Canadian Nuclear Isotope Council to host this exciting event. The Summit is now sold out, but attendees can learn more about the programming at

RT @IsotopesCanada: There are only five more days to register to attend the Canadian Radiotheranostics Leaders' Summit 2025!. Extremely lim….

Looking for a job in Canada’s medical isotope sector? . We recently update our job board! Visit our website to learn more about some of the many opportunities currently available across Canada’s medical isotope supply chain.

May is Brain Tumour Awareness Month, and the CMIE is pleased to join healthcare leaders and advocates across the country in raising awareness and supporting those impacted by brain tumours.

Canada’s medical isotope sector continues to increase production capacity thanks to our network of cyclotrons and fleet of reactors, two complimentary but unique technologies. You can learn more about Canadian isotope production on our website:

#ICYMI Researchers from the @UAlberta recently shared preliminary research demonstrating the potential of a new molecular imaging test which combines an antibody called panitumumab with copper-64. Learn more about this promising research here:

2/2 - As we see Canadian provinces increasingly publicly funding Pluvicto, we hope that considerations such as earlier use prior to chemotherapy will also be considered. Click here to read more about this news from Novartis:

1/2 - #ICYMI Novartis recently announced that the U.S. FDA has approved Pluvicto for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.

The CMIE team recently visited @McMasterU for a tour of the McMaster Nuclear Reactor, Canada’s most powerful research reactor. Thanks to Karin Stephenson for the tour of their nuclear facilities and for the innovative and truly life-changing work the team at McMaster leads.

Last week our Executive Chair, Holly Bilton, met with a delegation of nuclear medicine leaders from Belgium. These leaders visited Toronto & Hamilton to learn about 🇨🇦 nuclear medicine innovation & expand international business connections. Thanks for the great discussion!

RT @IsotopesCanada: 1/3 - We’re excited to begin our sponsor showcases ahead of the Canadian Radiotheranostics Leaders’ Summit 2025. Starti….

#ICYMI Nova Scotia and Alberta have now joined Ontario in publicly reimbursing #Pluvicto for eligible patients with prostate cancer. This is a significant step towards increasing access to life changing radiopharmaceuticals across the country. Read more:

We’re thrilled to support this innovative project through the CMIE’s Development Fund and look forward to keeping up with its progress. For more information on the CMIEDF, visit our website:

The RadioSyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise.

RadioSyn is designing & manufacturing a miniaturized automated radiochemical synthesis platform. By integrating continuous flow microfluidic engineering w/ automated synthesis capabilities, RadioSyn delivers a shielded synthesizer that eliminates traditional production barriers.

#ICYMI Last week, we announced the three successful projects from our second call for proposals. We’re excited to introduce you to these three companies leading exciting and innovative projects which are now being supported by the CMIE’s Development Fund. First up is RadioSyn.

Did you know that @Bruce_Power recently completed the largest harvest of cobalt-60 in its history? This historic harvest occurred during the planned outage of Unit 5 at Bruce Power’s Nuclear Generating Station in Kincardine, Ontario. Read more here:

We're pleased to announce the results from our 2nd call for proposals! . 3 medical isotope programs were selected to receive a total of $1.48 million in funding through the CMIEDF. Congratulations to @promationcanada , RadioSyn, and RC14. Read more here: